The Emergence of Hepatitis C Virus Genotype 4d among HIV-Infected Patients in Mexico City

Sexually Transmitted Diseases ◽

10.1097/olq.0000000000001596 ◽

2022 ◽

Vol Publish Ahead of Print ◽

Author(s):

Bruno Ali Lopez Luis ◽

Roberto Rodríguez-Díaz ◽

Luis Angulo-Medina ◽

Luis Enrique Soto-Ramírez

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Mexico City ◽

Virus Genotype

Download Full-text

IL28B genetic variation and ratio of y-GT/ALT as predictors for virological response in chronic hepatitis C virus genotype 1 infected patients

Zeitschrift für Gastroenterologie ◽

10.1055/s-0031-1295892 ◽

2012 ◽

Vol 50 (01) ◽

Author(s):

A Amanzada ◽

S Schneider ◽

F Moriconi ◽

M Blaschke ◽

T Suermann ◽

...

Keyword(s):

Genetic Variation ◽

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Virological Response ◽

Genotype 1 ◽

Virus Genotype ◽

Chronic Hepatitis C Virus

Download Full-text

Faculty Opinions recommendation of The relative efficacy of boceprevir and telaprevir in the treatment of hepatitis C virus genotype 1.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717967213.793466971 ◽

2012 ◽

Author(s):

Reto Nüesch

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Relative Efficacy ◽

Genotype 1 ◽

Virus Genotype

Download Full-text

Faculty Opinions recommendation of Characterization of virologic escape in hepatitis C virus genotype 1b patients treated with the direct-acting antivirals daclatasvir and asunaprevir.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717969197.793470534 ◽

2013 ◽

Author(s):

Cihan Yurdaydin

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Direct Acting Antivirals ◽

Virus Genotype ◽

Genotype 1B ◽

Direct Acting

Download Full-text

Faculty of 1000 evaluation for Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718020710.793480337 ◽

2013 ◽

Author(s):

Philip Rosenthal

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Phase 2 ◽

Genotype 1 ◽

Virus Genotype ◽

Double Blind ◽

Phase 2 Trial ◽

Pegylated Interferon Alfa

Download Full-text

Faculty Opinions recommendation of Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection--a randomized trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718061915.793484659 ◽

2013 ◽

Author(s):

Cihan Yurdaydin

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C Virus ◽

Hepatitis C ◽

Randomized Trial ◽

Dose Reduction ◽

Chronic Hepatitis C ◽

Genotype 1 ◽

Virus Genotype ◽

Chronic Hepatitis C Virus

Download Full-text

Faculty Opinions recommendation of Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718196356.793490906 ◽

2014 ◽

Author(s):

Arthur Kim

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Randomized Trial ◽

Low Dose ◽

Pegylated Interferon ◽

Genotype 1 ◽

Virus Genotype ◽

Interferon Α2a ◽

Treatment Naïve

Download Full-text

Faculty Opinions recommendation of Efficacy of sofosbuvir plus ribavirin with or without peginterferon-alfa in patients with hepatitis C virus genotype 3 infection and treatment-experienced patients with cirrhosis and hepatitis C virus genotype 2 infection.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725702749.793515296 ◽

2016 ◽

Author(s):

Adriaan van der Meer

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Genotype 3 ◽

Virus Genotype ◽

Genotype 2 ◽

Peginterferon Alfa

Download Full-text

Faculty Opinions recommendation of Randomized phase 3 trial of ombitasvir/paritaprevir/ritonavir for hepatitis C virus genotype 1b-infected Japanese patients with or without cirrhosis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725618099.793508090 ◽

2015 ◽

Author(s):

Philip Rosenthal

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Japanese Patients ◽

Virus Genotype ◽

Phase 3 ◽

Genotype 1B

Download Full-text

Synthesis, docking, and biological evaluation of thiazolidinone derivatives against hepatitis C virus genotype 4a

Medicinal Chemistry Research ◽

10.1007/s00044-021-02721-w ◽

2021 ◽

Author(s):

Ahmed S. Al-Behery ◽

Kamel M. Elberembally ◽

Mohammed A. Eldawy

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Biological Evaluation ◽

Virus Genotype

Download Full-text

Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3, randomized study

Hepatology ◽

10.1002/hep.28467 ◽

2016 ◽

Vol 64 (2) ◽

pp. 370-380 ◽

Cited By ~ 134

Author(s):

Paul Kwo ◽

Norman Gitlin ◽

Ronald Nahass ◽

David Bernstein ◽

Kyle Etzkorn ◽

...

Keyword(s):

Hepatitis C Virus ◽

Hepatitis C ◽

Randomized Study ◽

Genotype 1 ◽

Virus Genotype ◽

Phase 3

Download Full-text